Interventional Cardiology Market - Forecasts from 2019 to 2024

May 2019 | 108 pages | ID: I59BA8D824A0EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global interventional cardiology market is expected to reach US$25.092 billion by 2024 from US$19.069 billion in 2018 growing at a CAGR of 4.68%. Interventional cardiology is a minimally invasive procedure which utilizes catheter to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure. Catheters are medical devices consisting of thin tubes that can be inserted into the body to serve a broad range of functions. Interventional cardiology also helps to avoid surgery with treatments like angioplasty and valve repair or replacement. The interventional cardiology market is expected to show robust during the forecast period owing to the rising adoption of the minimally invasive procedure and rising incidences of cardiovascular diseases. As per data by WHO, cardiovascular diseases are leading cause of death globally with an estimated 17.9 million people dying of CVDs in 2016. Technological advancements in interventional cardiology devices will also boost the market for interventional cardiology during the forecast period. However, stringent regulatory requirements for the approval of interventional cardiology devices might restrain the growth of interventional cardiology market during the given time frame.

DRIVERS

Increasing prevalence of cardiovascular diseases.

Technological advancements in interventional cardiology devices.

Increasing health expenditure worldwide.

RESTRAINTS

Regulations regarding approval of interventional cardiology devices.

High cost of interventional cardiology procedures in developing and underdeveloped economies.

INDUSTRY UPDATE

In March 2019, Medtronic entered in an agreement with the Medical University of South Carolina with the aim to help the patients by delivering the best treatments at a lower cost. In addition, this is considered as a value-based agreement in order to help identify and diagnose the patients sooner.

In April 2018, BIOTRONIK US and Aziyo announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States.

The major players profiled in the global interventional cardiology market include Medtronic, Stryker, Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cordis (A Cardinal Health Company), Edwards Lifesciences Corporation, GE Healthcare, Biosensors International Group, Ltd., and Biotronik, Inc. among others.

Segmentation

The global interventional cardiology market has been analyzed through the following segments:

By Device Type

Stents

Catheters

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons

Others

By Application

Coronary Artery Disease

Heart Valve Disease

Peripheral Vascular Disease

Structural Heart Disease

By End-User

Hospitals and Clinics

Ambulatory Surgery Centers

By Geography

North America

USA

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

United Kingdom

Germany

France

Others

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

Asia Pacific

China

India

Australia

South Korea

Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET BY DEVICE TYPE

5.1. Stents
5.2. Catheters
5.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.4. Others

6. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET BY APPLICATION

6.1. Coronary Artery Disease
6.2. Heart Valve Disease
6.3. Peripheral Vascular Disease
6.4. Structural Heart Disease

7. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET BY END-USER

7.1. Hospitals And Clinics
7.2. Ambulatory Surgery Centers

8. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. United Kingdom
  8.3.2. Germany
  8.3.3. France
  8.3.4. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. UAE
  8.4.3. Israel
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Australia
  8.5.4. South Korea
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. Medtronic
10.2. Stryker
10.3. Abbott
10.4. B. Braun Melsungen AG
10.5. Boston Scientific Corporation
10.6. Cordis (A Cardinal Health Company)
10.7. Edwards Lifesciences Corporation
10.8. GE Healthcare
10.9. Biosensors International Group, Ltd.
10.10. Biotronik, Inc.
LIST OF FIGURES
LIST OF TABLES